No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: A meta-analysis based on 9,710 cases and 11,041 controls

Breast Cancer Research and Treatment

Volumn 122, Issue 2, 2010, Pages 509-514

  Ma, Xiangyu ^a   Chen, Chunhai ^a   Xiong, Hongyan ^a   Fan, Jin ^b   Li, Yafei ^a   Lin, Hui ^a   Xu, Rufu ^a   Huang, Guorong ^a   Xu, Bin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

Breast cancer; Meta analysis; Polymorphism; SOD2; Susceptibility.

Indexed keywords

ALANINE; MANGANESE SUPEROXIDE DISMUTASE; VALINE; SUPEROXIDE DISMUTASE;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; DOMINANT INHERITANCE; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MENOPAUSE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SYSTEMATIC REVIEW; BREAST TUMOR; CASE CONTROL STUDY; ENZYMOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PHENOTYPE; RISK; RISK ASSESSMENT; RISK FACTOR;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 77955661858     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0725-2     Document Type: Article

References (37)

1. Koksoy C, Kavas GO, Akcil E, Kocaturk PA, Kara S, Ozarslan C (1997) Trace elements and superoxide dismutase in benign and malignant breast diseases. Breast Cancer Res Treat 45:1-6.
2. DiSilvestro RA, Goodman J, Dy E, Lavalle G (2005) Soy isoflavone supplementation elevates erythrocyte superoxide dismutase, but not plasma ceruloplasmin in postmenopausal breast cancer survivors. Breast Cancer Res Treat 89:251-255. doi: 10.1007/s10549-004-2227-6. (Pubitemid 43293072)
3. Emerit I (1994) Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radic Biol Med 16:99-109.
4. Feig DI, Reid TM, Loeb LA (1994) Reactive oxygen species in tumorigenesis. Cancer Res 54:1890s-1894s.
5. Bica CG, de Moura da Silva LL, Toscani NV, da Cruz IB, Sa G, Graudenz MS, Zettler CG (2009) MnSOD gene polymorphism association with steroid-dependent cancer. Pathol Oncol Res 15:19-24. doi:10.1007/s12253-008-9064-6.
6. Kattan Z, Minig V, Leroy P, Dauca M, Becuwe P (2008) Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells. Breast Cancer Res Treat 108:203-215. doi:10.1007/s10549-007-9597-5. (Pubitemid 351311363)
7. Eras-Erdogan N, Akbas E, Senli H, Kul S, Colak T (2009) Relationship between polymorphism in the manganese superoxide dismutase gene and breast cancer. Mutat Res. doi: S1383-5718(09)00272-1[pii]10.1016/j.mrgentox.2009.08. 006.
8. Rosenblum JS, Gilula NB, Lerner RA (1996) On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci USA 93:4471-4473.
9. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012. doi: jst00003[pii].
10. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, Hanson J, Khoury M, Lau J, O'Brien TR, Rothman N, Stroup D, Taioli E, Thomas D, Vainio H, Wacholder S, Weinberg C (2002) Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156:300-310.
11. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
12. DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28:105-114. doi:S1551-7144(06) 00048-6[pii]10.1016/j.cct.2006. 04.004.
13. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188. doi:0197-2456(86)90046-2[pii].
14. Kostrykina NA, Pechkovskiy EA, Boyarskikh UA, Sushko AG, Voronina EN, Lazarev AF, Petrova VD, Zarubina NA, Selezneva IA, Sinkina TV, Terekhova SA, Filipenko ML (2009) Associations of polymorphic variant of MnSOD gene with breast cancer in residents of the Altai Region. Bull Exp Biol Med 147:84-87.
15. Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H (2008) Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat 108:137-149. doi:10.1007/s10549-007-9586-8. (Pubitemid 351623246)
16. Slanger TE, Chang-Claude J, Wang-Gohrke S (2006) Manganese superoxide dismutase Ala-9Val polymorphism, environmental modifiers, and risk of breast cancer in a German population. Cancer Causes Control 17:1025-1031. doi:10.1007/s10552-006-0043-5. (Pubitemid 44290767)
17. Silva SN, Cabral MN, Bezerra de Castro G, Pires M, Azevedo AP, Manita I, Pina JE, Rueff J, Gaspar J (2006) Breast cancer risk and polymorphisms in genes involved in metabolism of estrogens (CYP17, HSD17beta1, COMT and MnSOD): possible protective role of MnSOD gene polymorphism Val/Ala and Ala/Ala in women that never breast fed. Oncol Rep 16:781-788.
18. Gaudet MM, Gammon MD, Santella RM, Britton JA, Teitelbaum SL, Eng SM, Terry MB, Bensen JT, Schroeder J, Olshan AF, Neugut AI, Ambrosone CB (2005) MnSOD Val-9Ala genotype, pro- and anti-oxidant environmental modifiers, and breast cancer among women on Long Island, New York. Cancer Causes Control 16:1225-1234. doi:10.1007/s10552-005-0375-6. (Pubitemid 46179506)
19. Bergman M, Ahnstrom M, Palmeback Wegman P, Wingren S (2005) Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women. J Cancer Res Clin Oncol 131:439-444. doi:10.1007/s00432-004- 0663-7.
20. Cheng TC, Chen ST, Huang CS, Fu YP, Yu JC, Cheng CW, Wu PE, Shen CY (2005) Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113:345-353. doi:10.1002/ijc.20630. (Pubitemid 40038699)
21. Tamimi RM, Hankinson SE, Spiegelman D, Colditz GA, Hunter DJ (2004) Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 13:989-996. doi:13/6/989 [pii].
22. Cai Q, Shu XO, Wen W, Cheng JR, Dai Q, Gao YT, Zheng W (2004) Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res 6:R647-R655. doi:bcr929[pii]10.1186/bcr929.
23. Millikan RC, Player J, de Cotret AR, Moorman P, Pittman G, Vannappagari V, Tse CK, Keku T (2004) Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Res 6:R264-R274. doi:10.1186/bcr786 [pii].
24. Knight JA, Onay UV, Wells S, Li H, Shi EJ, Andrulis IL, Ozcelik H (2004) Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 13:146-149. (Pubitemid 38116633)
25. Egan KM, Thompson PA, Titus-Ernstoff L, Moore JH, Ambrosone CB (2003) MnSOD polymorphism and breast cancer in a population-based case-control study. Cancer Lett 199:27-33. doi: S0304383503003495[pii].
26. Mitrunen K, Sillanpaa P, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Uusitupa M, Hirvonen A (2001) Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 22:827-829.
27. Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Shields PG (1999) Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 59:602-606.
28. Kocabas NA, Sardas S, Cholerton S, Daly AK, Elhan AH, Karakaya AE (2005) Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility. Cell Biochem Funct 23:73-76. doi:10.1002/cbf.1128. (Pubitemid 40065178)
29. Ma XY, QI XW, Chen CH, Lin H, Xiong HY, Li YF, Jiang J (2009) Association between CYP19 polymorphisms and breast cancer risk: results from 10592 cases and 11720 controls. Breast Cancer Res Treat. doi:10.1007/s10549-009-0693-6.
30. Zhang Z, Wang M, Wu D, Tong N, Tian Y (2009) P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0480-4.
31. Wang Z, Fu Y, Tang C, Lu S, Chu WM (2009) SULT1A1 R213H polymorphism and breast cancer risk: a meta-analysis based on 8, 454 cases and 11, 800 controls. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0648-y.
32. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H (2009) Metaanalysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat. doi:10.1007/s10549-009-0593-9.
33. Tang C, Chen N, Wu M, Yuan H, Du Y (2009) Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 117: 391-399. doi:10.1007/s10549-008-0262-4.
34. Tao W, Wang C, Han R, Jiang H (2009) HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 114:371-376. doi:10.1007/s10549-008-0010-9.
35. Sergentanis TN, Economopoulos KP (2009) Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis. Breast Cancer Res Treat. doi:10.1007/s10549-009-0471-5.
36. Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC (2009) Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46, 281 subjects. Breast Cancer Res Treat. doi:10.1007/s10549-009- 0636-2.
37. Sergentanis TN, Economopoulos KP (2009) GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. doi:10.1007/s10549-009-0520-0.